Press release
2025-2034 Apixaban Market Evolution: Disruptions, Innovations, and Untapped Opportunities
Apixaban
What Is the Expected CAGR for the Apixaban Market Through 2025?
In the past few years, the apixaban market has been experiencing substantial growth. Projections indicate that its size will increase from $2.92 billion in 2024 to $3.19 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.2%. The surge observed in the historic period is a result of several factors, including the rising occurrence of atrial fibrillation, the aging demographic, regulatory approvals and market expansion, positive clinical results, and a transition from warfarin to NOACs.
What's the Projected Size of the Global Apixaban Market by 2029?
In the coming years, the apixaban market is predicted to experience robust growth, expanding to $4.48 billion by 2029 with a compound annual growth rate of 8.8%. This expected growth within the forecast period can be credited to the continual occurrence of cardiovascular diseases, enhanced awareness and diagnostic rates, growth in emerging markets, the aging global populace, and alterations in health policies and reimbursements. The forecast period also highlights key trends such as advancements in medication delivery systems, heightened research and developments, innovative collaborations, FDA's approval of apixaban, and the rise of digital health and telemedicine.
View the full report here:
https://www.thebusinessresearchcompany.com/report/apixaban-global-market-report
Top Growth Drivers in the Apixaban Industry: What's Accelerating the Market?
The escalation in the number of cardiovascular disease cases is anticipated to fuel the apixaban market's expansion. Cardiovascular ailments, which comprise conditions like coronary artery disease, stroke, and heart failure affecting the heart and blood vessels, are on the rise. This upward trend is attributed to inactive lifestyles, inadequate eating habits, usage of tobacco, obesity, hypertension, diabetes, and an ageing population. Apixaban plays a vital role in cardio-vascular disease management by lowering the probability of blood clots and thereby preventing conditions such as stroke, deep vein thrombosis, and pulmonary embolism. As an illustration, the American Heart Association, a non-profit organization based in the US, reported in January 2024 that cardiovascular diseases led to 931,578 deaths, showing an increase of less than 3,000 fatalities from the 928,741 in 2023. Consequently, the escalating cases of cardiovascular disease are propelling the apixaban market's growth.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15979&type=smp
What Trends Will Shape the Apixaban Market Through 2029 and Beyond?
Leading corporations in the apixaban market, such as Tiefenbacher Pharmaceuticals from Germany, are stepping up their game in the competitive marketplace by introducing novel products like generic anticoagulant medicine. The move is a strategic bid to make treatments more affordable and accessible for patients, while also bolstering their own market presence. Generic anticoagulant medications serve to inhibit various elements of the coagulation mechanism, assisting in the prevention of stroke and other heart-related conditions. Tiefenbacher Pharmaceuticals introduced a generic version of Apixaban in Canada in October 2022, an oral anticoagulant that is used widely ranging from prophylaxis following elective knee or hip replacement surgery, to stroke prevention in patients with atrial fibrillation, and treating deep vein thrombosis and pulmonary embolism. In an endeavor to cater to the large and diverse group of thrombotic disorders, the firm has managed to formulate 2.5 mg and 5 mg anticoagulant tablets in their Indian laboratories which would be distributed across Canada, via collaborations with generic pharmaceutical corporations, with subsequent launch plans for other global markets. This tactical move presents substantial monetary savings for global healthcare apparatus and augments the reach of potentially life-transforming treatments to an increased number of patients.
What Are the Main Segments in the Apixaban Market?
The apixaban market covered in this report is segmented -
1) By Dosage Form: Capsule, Tablets
2) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)
3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Capsule: 2.5 mg Capsule, 5 mg Capsule
2) By Tablets: 2.5 mg Tablet, 5 mg Tablet
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15979&type=smp
Which Top Companies are Driving Growth in the Apixaban Market?
Major companies operating in the apixaban market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Company Limited, Fresenius Kabi AG, Hetero Drugs Ltd, Eisai Co. Ltd, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Aspen Pharmacare Holdings Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd, Medichem S.A., Centaur Pharmaceuticals Pvt. Ltd., Simson Pharma Limited, OPOCRIN SPA, Pinnacle Life Sciences Private Limited
Which Regions Will Dominate the Apixaban Market Through 2029?
North America was the largest region in the apixaban market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the apixaban market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15979
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025-2034 Apixaban Market Evolution: Disruptions, Innovations, and Untapped Opportunities here
News-ID: 4129595 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Apixaban
Apixaban Market Analysis Current Landscape and Future Outlook
The Apixaban market is expected to grow at a CAGR of 6.2% between 2025 and 2035, driven by the rising prevalence of cardiovascular diseases, increasing awareness of stroke prevention, and the growing preference for direct oral anticoagulants (DOACs) over traditional blood thinners.
Apixaban Market Overview
Apixaban is a factor Xa inhibitor that is widely used for the prevention and treatment of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and stroke…
Key Trend Reshaping the Apixaban Market in 2025: Rise Of Generic Apixaban Expand …
What market dynamics are playing a key role in accelerating the growth of the apixaban market?
The increase in cases of cardiovascular disease is anticipated to boost the expansion of the apixaban market. The term cardiovascular disease covers a variety of conditions that impact the heart and blood vessels, such as coronary artery disease, stroke, and heart failure. The escalation in cardiovascular diseases can be attributed to inactive lifestyles, poor nutrition,…
Primary Catalyst Driving Apixaban Market Evolution in 2025: Impact Of Cardiovasc …
What Is the Future Outlook for the Apixaban Market's Size and Growth Rate?
In the past few years, there has been significant growth in the apixaban market size. It is projected to ascend from $2.92 billion in 2024 to $3.19 billion in 2025, marking a compound annual growth rate (CAGR) of 9.2%. The growth observed in the historic period is due to factors such as the rising case of atrial fibrillation,…
Apixaban Prices Surge Amid Increased Demand for Anticoagulant Medications
𝐊𝐨𝐫𝐞𝐚 𝐀𝐩𝐢𝐱𝐚𝐛𝐚𝐧 𝐏𝐥𝐚𝐭𝐞 𝐏𝐫𝐢𝐜𝐞𝐬 𝐌𝐨𝐯𝐞𝐦𝐞𝐧𝐭 𝐐𝟏
𝐀𝐩𝐢𝐱𝐚𝐛𝐚𝐧 𝐏𝐥𝐚𝐭𝐞 𝐏𝐫𝐢𝐜𝐞𝐬 𝐢𝐧 𝐊𝐨𝐫𝐞𝐚:
As for apixaban, by March 2024, the prices available in South Korea was 43,000 USD/Ton The price during the first quarter was much the same as had been observed in the last quarter for all practical purposes, with little variation from changes in demand and production dynamics. The usage of widely prescribed blood-thinning medication apixaban maintained steady demand from health care…
Apixaban Market: Growth Dynamics, Trends, and Opportunities
Apixaban, an oral anticoagulant primarily used to prevent and treat blood clots, has become a cornerstone in modern medical practice. As an integral part of managing cardiovascular and thromboembolic disorders, its role in healthcare continues to expand. This article delves into the Apixaban market, covering its size, evolution, trends, growth drivers, and the increasing demand propelling its trajectory.
Market Size
Data Bridge Market Research analyses a growth rate in the global apixaban…
Apixaban Market Overview, Trends And Forecast 2024-2033
The new report published by The Business Research Company, titled ""Apixaban Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the apixaban market size has grown strongly in recent years. It will grow from $2.69 billion in 2023 to…
